Description
Rahika 150mg tablet contains the active ingredient Capmatinib. It is an anti-cancer medicine that belongs to the class of medications called protein kinase inhibitors. It is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other body parts or is caused by a change (mutation) in a gene that makes an enzyme called MET in adults.
Do not take this medicine if you are allergic to Rahika 150mg tablet or any ingredients. Inform the physician if you have or have ever had lung or breathing problems other than your lung cancer, liver problems, or pancreatic problems. Inform your physician if you have any symptoms of an allergic reaction, including rash, hives, fever, difficulty breathing, or low blood pressure. This medicine is not recommended for children and adolescents below 18 years of age.
Avoid getting pregnant and breastfeeding during the treatment. Use effective contraception to avoid pregnancy. The common side effects of Rahika 150mg tablet are swelling in the face, and body, nausea, tiredness, vomiting, shortness of breath, and decreased appetite.
We have strong global networks in AFRICA, Europe, United Kingdom, United States, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, Unites Arab Emirates, Thailand, Vietnam, Middle East and South East Countries.
Explore more products anti cancer
Reviews
There are no reviews yet.